Delivery Order SPE2DB24D2100-SPE2DB25FBDBY

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,193.38 Firm Fixed Price Delivery Order is for the supply of 4566088090 CYCLOSPORINE 0.05% EYE EMULS 60S and has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of the prime contractor Amerisourcebergen Drug Corp. The $1,364.37 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, is leveraging its extensive supply chain to provide this medication to support military treatment programs and facilities. The...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,130.88 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,816.49 delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the Defense Logistics Agency Troop Support Medical, running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,593.29 firm fixed-price delivery order is for the supply of 4563283579 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a period of performance through January 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $2,096.36 and is a Firm Fixed Price Delivery Order that runs through March 2025. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a prescription eye medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $18,302.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cyclosporine 0.05% eye emulsion, a specialized ophthalmic medication, to support military healthcare programs. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price Delivery Order. This award is part of AmerisourceBergen's...
This federal contract award, valued at $1,084.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567422578 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a firm fixed price and an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,466.71 Firm Fixed Price Delivery Order contract is for the supply of CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product, with a period of performance through March 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $46,507.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of CYCLOSPORINE 0.05% EYE EMULSION, a pharmaceutical product, with a period of performance through November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBDBY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,525.76 firm fixed-price delivery order is for the supply of CYCLOSPORINE 0.05% EYE EMULSION 60S, a specialty ophthalmic medication. The award has an ultimate completion date of March 28, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of that larger IDC, demonstrating Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract does not have a set-aside designation, indicating open competition.

Generated 6/26/25, 10:08 AM